StemRIM

4599.TTSE GROWTHPharmaceutical
Major holders (5%+) · 2
HolderStakeChangeFiled
Gomi Daisuke7.32%—2024-06-14
Tomita Kensuke5.52%-1.20pp2026-08-27

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 1
ECS0.67%2026-07-07
Ownership history · 7
FiledHolderRatioChangePurpose
2026-07-07AmendedECS2026-07-07 · amended0.67%-0.01ppStable shareholder
2026-07-07AmendedTomita Kensuke2026-07-07 · amended4.84%-1.21ppStable shareholder
2026-07-07AmendedECS2026-07-07 · amended0.68%no changeStable shareholder
2026-07-07AmendedTomita Kensuke2026-07-07 · amended6.05%-1.20ppStable shareholder
2026-07-07AmendedECS2026-07-07 · amended0.68%newStable shareholder
2026-07-07AmendedTomita Kensuke2026-07-07 · amended7.25%newStable shareholder
2024-06-14AmendedGomi Daisuke2024-06-14 · amended7.32%newPure investment

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.